Cash & equivalents increased 59.6%
Cash & equivalents changed +59.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$272.0M→$434.0M2 prior comparisons
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +59.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Net income changed +170.3% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.